山东大学学报 (医学版) ›› 2020, Vol. 58 ›› Issue (7): 67-71.doi: 10.6040/j.issn.1671-7554.0.2020.0486
• • 上一篇
徐玉香1,2,刘煜东1,3,张蓬1,3,段瑞生1,3
XU Yuxiang1,2, LIU Yudong1,3, ZHANG Peng1,3, DUAN Ruisheng1,3
摘要: 目的 探讨脑小血管病(CSVD)患者脑微出血(CMBs)的独立危险因素。 方法 回顾性收集符合脑小血管病影像学诊断的患者101例,按是否存在CMBs分为CMBs组和非CMBs组,统计学分析识别CMBs的危险因素和保护因素。 结果 与CSVD中非CMBs组患者比较,CMBs组患者中高血压所占比例较高(χ2=9.879, P=0.002),超敏C反应蛋白(hs-CRP)(t=2.294, P=0.024)、同型半胱氨酸(Hcy)(t=2.193, P=0.031)、半胱氨酸蛋白酶抑制剂C(Cys-C)(t=2.160, P=0.034)、脂蛋白a(Lpa)(t=4.247, P<0.001)水平较高,低密度脂蛋白胆固醇(LDL-c)(t=-3.342, P=0.001)水平较低。Logistic回归分析结果显示,高血压(P=0.002, OR=6.706, 95%CI:2.011~22.362)、hs-CRP(P=0.049, OR=1.279,95%CI:1.001~1.635)、Lpa(P=0.001,OR=1.006,95%CI:1.003~1.009)和LDL-c(P=0.039, OR=0.472,95%CI:0.232~0.963)与CMBs独立相关。 结论 高血压、hs-CRP、Lpa是CMBs的独立危险因素,LDL-c是CMBs的保护因素。
中图分类号:
[1] Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges [J]. Lancet Neurol, 2010, 9(7): 689-701. [2] Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration [J]. Lancet Neurol, 2013, 12(8): 822-838. [3] Martinez-Ramirez S, Pontes-Neto OM, Dumas AP, et al. Topography of dilated perivascular spaces in subjects from a memory clinic cohort [J]. Neurology, 2013, 80(17): 1551-1556. [4] van Agtmaal MJM, Houben A, Pouwer F, et al. Association of microvascular dysfunction with late-life depression: a systematic review and meta-analysis [J]. JAMA Psychiatry, 2017, 74(7): 729-739. [5] Lee J, Sohn EH, Oh E, et al. Characteristics of cerebral microbleeds [J]. Dement Neurocogn Disord, 2018, 17(3): 73-82. [6] Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation [J]. Lancet Neurol, 2009, 8(2): 165-174. [7] Shoamanesh A, Kwok CS, Benavente O. Cerebral microbleeds: histopathological correlation of neuroimaging [J]. Cerebrovasc Dis, 2011, 32(6): 528-534. [8] Haller S, Vernooij MW, Kuijer JPA, et al. Cerebral microbleeds: imaging and clinical significance [J]. Radiology, 2018, 287(1): 11-28. [9] Wu Y, Chen T. An up-to-date review on cerebral microbleeds [J]. J Stroke Cerebrovasc Dis, 2016, 25(6): 1301-1306. [10] Romero JR, Preis SR, Beiser A, et al. Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study [J]. Stroke, 2014, 45(5): 1492-1494. [11] Akoudad S, Darweesh SK, Leening MJ, et al. Use of coumarin anticoagulants and cerebral microbleeds in the general population [J]. Stroke, 2014, 45(11): 3436-3439. [12] Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting [J]. Brain, 2007, 130(Pt 8): 1988-2003. [13] Liu W, Liu R, Sun W, et al. Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions [J]. Stroke, 2012, 43(11): 2916-2922. [14] Ferretti G, Bacchetti T, Johnston TP, et al. Lipoprotein(a): a missing culprit in the management of athero-thrombosis? [J]. J Cell Physiol, 2018, 233(4): 2966-2981. [15] Low A, Mak E, Rowe JB, et al. Inflammation and cerebral small vessel disease: a systematic review [J]. Ageing Res Rev, 2019, 53: 100916. doi: 10.1016/j.arr.2019.100916. [16] Ma C, Na M, Neumann S, et al. Low-density lipoprotein cholesterol and risk of hemorrhagic stroke: a systematic review and dose-response meta-analysis of prospective studies [J]. Curr Atheroscler Rep, 2019, 21(12): 52. [17] Lee SH, Lee ST, Kim BJ, et al. Dynamic temporal change of cerebral microbleeds: long-term follow-up MRI study [J]. PLoS One, 2011, 6(10): e25930. doi: 10.1371/journal. pone. 0025930. [18] Bruckdorfer KR, Demel RA, De Gier J, et al. The effect of partial replacements of membrane cholesterol by other steroids on the osmotic fragility and glycerol permeability of erythrocytes [J]. Biochim Biophys Acta, 1969, 183(2): 334-345. [19] Rosenson RS, Lowe GD. Effects of lipids and lipoproteins on thrombosis and rheology [J]. Atherosclerosis, 1998, 140(2): 271-280. [20] Lee SH, Bae HJ, Yoon BW, et al. Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions [J]. Stroke, 2002, 33(12): 2845-2849. [21] Ma Y, Li Z, Chen L, et al. Blood lipid levels, statin therapy and the risk of intracerebral hemorrhage [J]. Lipids Health Dis, 2016, 15: 43. doi: 10.1186/s12944-016-0213-8. [22] Mitaki S, Nagai A, Oguro H, et al. C-reactive protein levels are associated with cerebral small vessel-related lesions [J]. Acta Neurol Scand, 2016, 133(1): 68-74. [23] Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells [J]. Circulation, 2000, 102(18): 2165-2168. [24] Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein [J]. Circulation, 2002, 105(16): 1890-1896. [25] Khreiss T, Jozsef L, Potempa LA, et al. Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells [J]. Circulation, 2004, 109(16): 2016-2022. [26] Kaaouana T, de Rochefort L, Samaille T, et al. 2D harmonic filtering of MR phase images in multicenter clinical setting: toward a magnetic signature of cerebral microbleeds [J]. Neuroimage, 2015, 104: 287-300. doi: 10.1016/j.neuroimage.2014.08.024. |
No related articles found! |
|